angiotensin ii has been researched along with Venous Thrombosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chabielska, E; Dzieciol, J; Gradzka, A; Gromotowicz-Poplawska, A; Kramkowski, K; Stankiewicz, A; Szemraj, J; Wojewodzka-Zelezniakowicz, M | 1 |
| Buczko, W; Kucharewicz, I; Matys, T; Pawlak, D; Pawlak, R | 1 |
| Buczko, W; Chabielska, E; Mogielnicki, A; Pawlak, R; Szemraj, J | 1 |
3 other study(ies) available for angiotensin ii and Venous Thrombosis
| Article | Year |
|---|---|
The acute prothrombotic effect of aldosterone in rats is partially mediated via angiotensin II receptor type 1.
Topics: Aldosterone; Angiotensin II; Animals; Blood Coagulation; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Venous Thrombosis | 2016 |
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epoprostenol; Fibrinolytic Agents; Hypertension, Renal; Imidazoles; Infusions, Intravenous; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Venous Thrombosis | 2002 |
Angiotensin II enhances thrombosis development in renovascular hypertensive rats.
Topics: alpha-2-Antiplasmin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin III; Animals; Blood Pressure; Carotid Arteries; Fibrin; Heart Rate; Hypertension, Renovascular; Infusions, Intravenous; Losartan; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Recombinant Proteins; Regional Blood Flow; Tissue Plasminogen Activator; Venous Thrombosis | 2005 |